Literature DB >> 16414987

Contribution of C/EBP proteins to Epstein-Barr virus lytic gene expression and replication in epithelial cells.

Jian Huang1, Gangling Liao, Honglin Chen, Frederick Y Wu, Lindsey Hutt-Fletcher, Gary S Hayward, S Diane Hayward.   

Abstract

The contribution of C/EBP proteins to Epstein-Barr virus (EBV) lytic gene expression and replication in epithelial cells was examined. Nasopharyngeal carcinoma cell lines constitutively expressed C/EBPbeta and had limited C/EBPalpha expression, while the AGS gastric cancer cell line expressed significant levels of both C/EBPalpha and C/EBPbeta. Induction of the lytic cycle in EBV-positive AGS/BX1 cells with phorbol ester and sodium butyrate treatment led to a transient stimulation of C/EBPbeta expression and a prolonged increase in C/EBPalpha expression. In AGS/BX1 cells, endogenous C/EBPalpha and C/EBPbeta proteins were detected associated with the ZTA and oriLyt promoters but not the RTA promoter. Electrophoretic mobility shift assays confirmed binding of C/EBP proteins to multiple sites in the ZTA and oriLyt promoters. The response of these promoters in reporter assays to transfected C/EBPalpha and C/EBPbeta proteins was consistent with the promoter binding assays and emphasized the relative importance of C/EBPs for activation of the ZTA promoter. Mutation of the oriLyt promoter proximal C/EBP site had little effect on ZTA activation of the promoter in a reporter assay. However, this mutation impaired oriLyt DNA replication, suggesting a separate replication-specific contribution for C/EBP proteins. Finally, the overall importance of C/EBP proteins for lytic gene expression was demonstrated using CHOP10 to antagonize C/EBP DNA binding activity. Introduction of CHOP10 significantly impaired induction of the ZTA, RTA, and BMRF1 proteins in chemically treated AGS/BX1 cells. Thus, C/EBPbeta and C/EBPalpha expression are associated with lytic induction in AGS cells, and expression of C/EBP proteins in epithelial cells may contribute to the tendency of these cells to exhibit constitutive low-level ZTA promoter activity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16414987      PMCID: PMC1346937          DOI: 10.1128/JVI.80.3.1098-1109.2006

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  74 in total

1.  Definition of the transcription factors which bind the differentiation responsive element of the Epstein-Barr virus BZLF1 Z promoter in human epithelial cells.

Authors:  P MacCallum; L Karimi; L J Nicholson
Journal:  J Gen Virol       Date:  1999-06       Impact factor: 3.891

2.  Identification of a negative cis element within the ZII domain of the Epstein-Barr virus lytic switch BZLF1 gene promoter.

Authors:  P Liu; S Liu; S H Speck
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

3.  Characterization of the ZI domains in the Epstein-Barr virus BZLF1 gene promoter: role in phorbol ester induction.

Authors:  A M Borras; J L Strominger; S H Speck
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

4.  The Epstein-Barr virus bZIP transcription factor Zta causes G0/G1 cell cycle arrest through induction of cyclin-dependent kinase inhibitors.

Authors:  C Cayrol; E K Flemington
Journal:  EMBO J       Date:  1996-06-03       Impact factor: 11.598

5.  Characterization of proteins binding to the ZII element in the Epstein-Barr virus BZLF1 promoter: transactivation by ATF1.

Authors:  Y C Wang; J M Huang; E A Montalvo
Journal:  Virology       Date:  1997-01-20       Impact factor: 3.616

6.  The Epstein-Barr virus-induced Ca2+/calmodulin-dependent kinase type IV/Gr promotes a Ca(2+)-dependent switch from latency to viral replication.

Authors:  T Chatila; N Ho; P Liu; S Liu; G Mosialos; E Kieff; S H Speck
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

7.  The keratinocyte-specific Epstein-Barr virus ED-L2 promoter is regulated by phorbol 12-myristate 13-acetate through two cis-regulatory elements containing E-box and Krüppel-like factor motifs.

Authors:  T D Jenkins; H Nakagawa; A K Rustgi
Journal:  J Biol Chem       Date:  1997-09-26       Impact factor: 5.157

8.  CCAAT/enhancer binding protein alpha regulates p21 protein and hepatocyte proliferation in newborn mice.

Authors:  N A Timchenko; T E Harris; M Wilde; T A Bilyeu; B L Burgess-Beusse; M J Finegold; G J Darlington
Journal:  Mol Cell Biol       Date:  1997-12       Impact factor: 4.272

9.  Cyclosporin A-sensitive induction of the Epstein-Barr virus lytic switch is mediated via a novel pathway involving a MEF2 family member.

Authors:  S Liu; P Liu; A Borras; T Chatila; S H Speck
Journal:  EMBO J       Date:  1997-01-02       Impact factor: 11.598

10.  Epstein-Barr viral latency is disrupted by the immediate-early BRLF1 protein through a cell-specific mechanism.

Authors:  S Zalani; E Holley-Guthrie; S Kenney
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-20       Impact factor: 11.205

View more
  28 in total

1.  Plasma cell-specific transcription factor XBP-1s binds to and transactivates the Epstein-Barr virus BZLF1 promoter.

Authors:  Chia Chi Sun; David A Thorley-Lawson
Journal:  J Virol       Date:  2007-09-26       Impact factor: 5.103

2.  CCAAT/enhancer binding proteins play a role in oriLyt-dependent genome replication during MHV-68 de novo infection.

Authors:  Jing Qi; Danyang Gong; Hongyu Deng
Journal:  Protein Cell       Date:  2011-07-12       Impact factor: 14.870

3.  Essential role of Rta in lytic DNA replication of Epstein-Barr virus.

Authors:  Ayman El-Guindy; Maryam Ghiassi-Nejad; Sean Golden; Henri-Jacques Delecluse; George Miller
Journal:  J Virol       Date:  2012-10-17       Impact factor: 5.103

4.  Shutoff of BZLF1 gene expression is necessary for immortalization of primary B cells by Epstein-Barr virus.

Authors:  Xianming Yu; Patrick J McCarthy; Zhenxun Wang; Daniel A Gorlen; Janet E Mertz
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

5.  MicroRNA miR-BART20-5p stabilizes Epstein-Barr virus latency by directly targeting BZLF1 and BRLF1.

Authors:  Yu-Jin Jung; Hoyun Choi; Hyoji Kim; Suk Kyeong Lee
Journal:  J Virol       Date:  2014-06-04       Impact factor: 5.103

6.  Bortezomib induction of C/EBPβ mediates Epstein-Barr virus lytic activation in Burkitt lymphoma.

Authors:  Courtney M Shirley; Jianmeng Chen; Meir Shamay; Huili Li; Cynthia A Zahnow; S Diane Hayward; Richard F Ambinder
Journal:  Blood       Date:  2011-03-29       Impact factor: 22.113

7.  Protein inhibitor of activated STAT1 (PIAS1) inhibits IRF8 activation of Epstein-Barr virus lytic gene expression.

Authors:  Kun Zhang; Dong-Wen Lv; Renfeng Li
Journal:  Virology       Date:  2019-11-11       Impact factor: 3.616

8.  The Epstein-Barr virus BZLF1 protein inhibits tumor necrosis factor receptor 1 expression through effects on cellular C/EBP proteins.

Authors:  Jillian A Bristol; Amanda R Robinson; Elizabeth A Barlow; Shannon C Kenney
Journal:  J Virol       Date:  2010-09-22       Impact factor: 5.103

9.  Role of the TSG101 gene in Epstein-Barr virus late gene transcription.

Authors:  Huey-Huey Chua; Heng-Huan Lee; Shih-Shin Chang; Chih-Chung Lu; Te-Huei Yeh; Tsuey-Ying Hsu; Tzu-Hao Cheng; Jiin-Tsuey Cheng; Mei-Ru Chen; Ching-Hwa Tsai
Journal:  J Virol       Date:  2006-12-20       Impact factor: 5.103

10.  A protein encoded by the bovine herpesvirus 1 latency-related gene interacts with specific cellular regulatory proteins, including CCAAT enhancer binding protein alpha.

Authors:  Florencia Meyer; Sandra Perez; Vicki Geiser; Mark Sintek; Melissa Inman; Clinton Jones
Journal:  J Virol       Date:  2006-09-20       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.